FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer

Pancreatic cancer is an extremely aggressive disease; although progress has been made in the last few years, the prognosis of these patients remains dismal. FOLFIRINOX is now considered a standard treatment in first-line setting, since it demonstrated an improved overall and progression-free surviva...

詳細記述

保存先:
書誌詳細
出版年:World J Gastroenterol
主要な著者: Caparello, Chiara, Meijer, Laura L, Garajova, Ingrid, Falcone, Alfredo, Le Large, Tessa Y, Funel, Niccola, Kazemier, Geert, Peters, Godefridus J, Vasile, Enrico, Giovannetti, Elisa
フォーマット: Artigo
言語:Inglês
出版事項: Baishideng Publishing Group Inc 2016
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4988311/
https://ncbi.nlm.nih.gov/pubmed/27610011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i31.6987
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料